4LL.F
Teladoc Health, Inc.
FrankfurtEUREQUITY
Healthcare
DELAYED
Last price
5.50
▼ 0.13 (2.24%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
5.48
Prev close
5.62
Day high
5.50
Day low
5.48
Volume
80
Market cap
$998.90M
P/E (TTM)
—
52W range
3.71 – 8.57
Day trading desk
Gap from prior close
-2.52%
Prior close 5.62
VWAP
5.50
0.00% from price
Relative volume
0.09×
Quiet session
Session range
0.29%
5.48 – 5.50
Position in range
100%
Near session high
ATR (14D)
0.16
2.95% of price
Prior day high
5.65
PDH
Prior day low
5.62
PDL
Bid / ask spread
—
Quote not published
Session volume
80
Avg 885
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-7.60%
-6.2%
1M
-30.14%
-33.9%
3M
-1.26%
-4.4%
6M
+39.77%
+28.7%
YTD
-6.91%
-19.2%
1Y
-16.19%
-36.2%
3Y
-73.57%
-147.7%
5Y
-95.44%
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on 4LL.F open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
1.27M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Jul 6, 26 | BLISS KELLY Officer |
SELL | 2.50K | $23.75K | Direct |
| Jul 2, 26 | CATAPANO JOSEPH RONALD Officer |
SELL | 653 | $5.94K | Direct |
| Jul 1, 26 | CATAPANO JOSEPH RONALD Officer |
— | 2.08K | — | Direct |
| Jul 1, 26 | BLISS KELLY Officer |
SELL | 2.50K | $22.50K | Direct |
| Jun 29, 26 | BLISS KELLY Officer |
SELL | 2.50K | $21.25K | Direct |
| Jun 11, 26 | DIVITA CHARLESIII Chief Executive Officer |
SELL | 18.07K | $125.47K | Direct |
| Jun 10, 26 | DIVITA CHARLESIII Chief Executive Officer |
— | 42.80K | — | Direct |
| Jun 3, 26 | RODRIGUES FERNANDO MADEIRA Officer |
SELL | 9.57K | $70.83K | Direct |
| Jun 2, 26 | VANDERVOORT ADAM C Officer |
SELL | 7.91K | $60.30K | Direct |
| Jun 2, 26 | NUENO CARLOS PLANA Officer |
SELL | 6.20K | $47.26K | Direct |
| Jun 2, 26 | BLISS KELLY Officer |
SELL | 7.68K | $58.57K | Direct |
| Jun 2, 26 | RODRIGUES FERNANDO MADEIRA Officer |
SELL | 5.68K | $43.30K | Direct |
| Jun 2, 26 | DIVITA CHARLESIII Chief Executive Officer |
SELL | 19.13K | $145.92K | Direct |
| Jun 2, 26 | CATAPANO JOSEPH RONALD Officer |
SELL | 284 | $2.17K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BLISS KELLY |
Officer | 84.88K | Sale |
DIVITA CHARLESIII |
Chief Executive Officer | 414.62K | Sale |
JACOBSON CATHERINE |
Director | 66.85K | Conversion of Exercise of derivative security |
MURTHY MALA |
Chief Financial Officer | 142.38K | Sale |
NANIS NIKOLAOS P |
Chief Technology Officer | 75.41K | Sale |
NUENO CARLOS PLANA |
Officer | 57.67K | Sale |
SHEDLARZ DAVID L |
Director | 61.27K | Conversion of Exercise of derivative security |
SNOW DAVID B JR |
Director | 165.03K | Conversion of Exercise of derivative security |
VANDERVOORT ADAM C |
Officer | 110.26K | Sale |
WATERS MICHAEL WILLEM |
Chief Operating Officer | 78.31K | Sale |
Fundamentals
Market cap$998.90M
Enterprise value$1.26B
Revenue (TTM)$2.49B
Gross profit$1.72B
EBITDA$64.56M
Net income$-177.40M
EPS (TTM)$-0.85
Free cash flow$191.04M
Total cash$774.35M
Total debt$1.04B
Book value / share$6.17
Shares outstanding181.68M
Float180.51M
Short % of float—
Dividend yield—
Beta (5Y)2.13
Valuation & profitability ratios
Trailing P/E—
Forward P/E-3.90
PEG ratio—
Price / sales—
Price / book0.89
EV / revenue0.51
EV / EBITDA19.53
Gross margin68.97%
Operating margin-5.68%
Profit margin-7.13%
Return on equity-12.98%
Return on assets-3.22%
Debt / equity79.09
Current ratio0.83
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $2.53B | $2.57B | $2.60B | $2.41B | -1.5% |
| Operating revenue | $2.09B | $2.22B | $2.28B | $2.10B | -5.6% |
| Cost of revenue | $771.59M | $751.27M | $760.03M | $743.99M | +2.7% |
| Gross profit | $1.76B | $1.82B | $1.84B | $1.66B | -3.3% |
| Research & development | $277.92M | $307.27M | $348.52M | $333.63M | -9.6% |
| Selling, general & admin | $1.28B | $1.35B | $1.37B | $1.30B | -4.9% |
| Total operating expense | $1.92B | $2.03B | $2.05B | $1.89B | -5.2% |
| Operating income | -$163.40M | -$208.79M | -$210.50M | -$227.37M | +21.7% |
| Net interest income | $17.06M | $33.27M | $24.50M | -$9.27M | -48.7% |
| Pre-tax income | -$235.53M | -$993.65M | -$219.61M | -$13.66B | +76.3% |
| Tax provision | -$35.21M | $7.59M | $760.00K | -$3.81M | -563.8% |
| Net income | -$200.32M | -$1.00B | -$220.37M | -$13.66B | +80.0% |
| Net income to common | -$200.32M | -$1.00B | -$220.37M | -$13.66B | +80.0% |
| Basic EPS | -1.14 | -5.87 | -1.34 | -84.60 | +80.6% |
| Diluted EPS | -1.14 | -5.87 | -1.34 | -84.60 | +80.6% |
| EBIT | -$215.82M | -$969.85M | -$197.33M | -$13.64B | +77.7% |
| EBITDA | $160.62M | -$587.01M | $151.40M | -$13.37B | +127.4% |
| Basic shares | 176.22M | 170.56M | 162.17M | 161.46M | +3.3% |
| Diluted shares | 176.22M | 170.56M | 162.17M | 161.46M | +3.3% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $781.08M | $1.30B | $1.12B | $918.18M | -39.8% |
| Cash & short-term investments | $781.08M | $1.30B | $1.12B | $918.18M | -39.8% |
| Accounts receivable | $192.83M | $214.15M | $217.42M | $210.55M | -10.0% |
| Inventory | $38.20M | $38.14M | $29.51M | $56.34M | +0.2% |
| Total current assets | $1.12B | $1.66B | $1.49B | $1.32B | -32.7% |
| Property, plant & equipment | $53.09M | $56.58M | $72.09M | $71.47M | -6.2% |
| Goodwill & intangibles | $1.58B | $1.71B | $2.75B | $2.91B | -7.8% |
| Total assets | $2.86B | $3.52B | $4.39B | $4.35B | -18.7% |
| Total current liabilities | $404.74M | $941.53M | $420.62M | $399.77M | -57.0% |
| Current debt | — | $550.72M | — | — | — |
| Long-term debt | $994.92M | $991.42M | $1.54B | $1.54B | +0.4% |
| Total debt | $1.04B | $1.58B | $1.59B | $1.59B | -34.4% |
| Total liabilities | $1.47B | $2.03B | $2.07B | $2.04B | -27.3% |
| Retained earnings | -$16.43B | -$16.23B | -$15.23B | -$15.01B | -1.2% |
| Shareholder equity | $1.39B | $1.49B | $2.33B | $2.31B | -7.1% |
| Working capital | $714.39M | $722.37M | $1.07B | $915.62M | -1.1% |
| Net tangible assets | -$194.57M | -$223.47M | -$424.90M | -$602.21M | +12.9% |
| Shares issued | 178.32M | 173.41M | 166.66M | 162.84M | +2.8% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$200.32M | -$1.00B | -$220.37M | -$13.66B | +80.0% |
| Depreciation & amortisation | $376.43M | $382.84M | $348.72M | $267.78M | -1.7% |
| Stock-based compensation | $80.41M | $145.95M | $201.55M | $217.85M | -44.9% |
| Change in working capital | $1.07M | -$36.31M | $11.64M | -$48.39M | +103.0% |
| Operating cash flow | $294.36M | $293.68M | $350.02M | $189.29M | +0.2% |
| Capital expenditure | -$157.02M | -$124.05M | -$156.35M | -$172.76M | -26.6% |
| Investing cash flow | -$266.00M | -$124.05M | -$156.35M | -$167.74M | -114.4% |
| Financing cash flow | -$551.65M | $8.31M | $10.85M | $6.50M | -6,736.8% |
| Free cash flow | $137.33M | $169.63M | $193.67M | $16.53M | -19.0% |
| End cash position | $781.08M | $1.30B | $1.12B | $918.18M | -39.8% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $606.93M | $613.85M | $642.27M | $626.44M | $631.90M | -1.1% |
| Operating revenue | $474.21M | $484.65M | $521.60M | $520.91M | $523.70M | -2.2% |
| Cost of revenue | $190.84M | $197.53M | $197.05M | $187.18M | $190.54M | -3.4% |
| Gross profit | $416.09M | $416.32M | $445.22M | $439.26M | $441.36M | -0.1% |
| Research & development | $62.86M | $67.86M | $71.61M | $67.57M | $68.78M | -7.4% |
| Selling, general & admin | $296.82M | $304.90M | $305.74M | $318.77M | $325.61M | -2.6% |
| Total operating expense | $450.59M | $465.05M | $472.19M | $474.72M | $487.40M | -3.1% |
| Operating income | -$34.50M | -$48.73M | -$26.97M | -$35.46M | -$46.03M | +29.2% |
| Net interest income | $1.37M | $1.12M | $2.00M | $2.56M | $5.59M | +22.3% |
| Pre-tax income | -$37.91M | -$60.84M | -$33.62M | -$50.22M | -$40.42M | +37.7% |
| Tax provision | $997.00K | $3.00M | -$8.47M | -$715.00K | -$7.76M | -66.7% |
| Net income | -$38.91M | -$63.84M | -$25.14M | -$49.51M | -$32.66M | +39.1% |
| Net income to common | -$38.91M | -$63.84M | -$25.14M | -$49.51M | -$32.66M | +39.1% |
| Basic EPS | -0.21 | -10.80 | -0.14 | -0.28 | -0.19 | +98.1% |
| Diluted EPS | -0.21 | -10.80 | -0.14 | -0.28 | -0.19 | +98.1% |
| EBIT | -$32.80M | -$55.47M | -$28.67M | -$45.70M | -$35.95M | +40.9% |
| EBITDA | $59.60M | $38.71M | $70.55M | $46.46M | $58.94M | +54.0% |
| Basic shares | 181.03M | 5.97M | 177.83M | 176.93M | 175.92M | +2,931.9% |
| Diluted shares | 181.03M | 5.97M | 177.83M | 176.93M | 175.92M | +2,931.9% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $774.35M | $750.74M | $781.08M | $726.25M | $679.62M | — | +3.1% |
| Cash & short-term investments | $774.35M | $750.74M | $781.08M | $726.25M | $679.62M | — | +3.1% |
| Accounts receivable | $221.01M | $213.63M | $192.83M | $210.76M | $225.43M | — | +3.5% |
| Inventory | $28.82M | $31.56M | $38.20M | $39.90M | $38.16M | — | -8.7% |
| Total current assets | $1.15B | $1.13B | $1.12B | $1.09B | $1.07B | — | +1.4% |
| Property, plant & equipment | $47.41M | $50.51M | $53.09M | $59.28M | $53.17M | — | -6.1% |
| Goodwill & intangibles | $1.46B | $1.52B | $1.58B | $1.62B | $1.67B | — | -3.9% |
| Total assets | $2.76B | $2.81B | $2.86B | $2.88B | $2.89B | — | -1.7% |
| Total current liabilities | $1.38B | $404.87M | $404.74M | $405.09M | $401.77M | — | +241.3% |
| Current debt | $996.70M | — | — | — | — | $550.72M | — |
| Long-term debt | — | $995.81M | $994.92M | $994.04M | $993.16M | $992.29M | — |
| Total debt | $1.04B | $1.04B | $1.04B | $1.04B | $1.04B | — | -0.2% |
| Total liabilities | $1.45B | $1.47B | $1.47B | $1.49B | $1.47B | — | -1.5% |
| Retained earnings | -$16.53B | -$16.49B | -$16.43B | -$16.41B | -$16.36B | — | -0.2% |
| Shareholder equity | $1.31B | $1.34B | $1.39B | $1.39B | $1.42B | — | -2.0% |
| Working capital | -$233.37M | $727.47M | $714.39M | $687.67M | $671.50M | — | -132.1% |
| Net tangible assets | -$148.75M | -$182.06M | -$194.57M | -$227.73M | -$244.36M | — | +18.3% |
| Shares issued | 181.65M | 180.43M | 178.32M | 177.35M | 176.61M | — | +0.7% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$38.91M | -$63.84M | -$25.14M | -$49.51M | -$32.66M | +39.1% |
| Depreciation & amortisation | $92.41M | $94.19M | $99.22M | $92.15M | $94.89M | -1.9% |
| Stock-based compensation | $9.30M | $14.61M | $15.91M | $17.00M | $22.34M | -36.3% |
| Change in working capital | $107.00K | -$35.63M | $4.10M | $24.01M | $13.45M | +100.3% |
| Operating cash flow | $64.66M | $9.52M | $87.74M | $99.26M | $91.43M | +579.5% |
| Capital expenditure | -$41.59M | -$35.82M | -$34.32M | -$31.32M | -$59.80M | -16.1% |
| Investing cash flow | -$41.59M | -$36.52M | -$34.32M | -$48.72M | -$59.70M | -13.9% |
| Financing cash flow | $875.00K | -$2.45M | $1.10M | -$3.59M | -$549.93M | +135.7% |
| Free cash flow | $23.07M | -$26.31M | $53.42M | $67.95M | $31.63M | +187.7% |
| End cash position | $774.35M | $750.74M | $781.08M | $726.25M | $679.62M | +3.1% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $592.72M | -5.4% |
| Next quarter | — | — | $601.99M | -6.3% |
| Current year | — | — | $2.42B | -4.4% |
| Next year | — | — | $2.39B | -1.1% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders0.70%
Held by institutions87.15%
Institutions holding470
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
5.77
-4.69% from price
SMA 20
6.11
-10.02% from price
SMA 50
6.97
-21.12% from price
SMA 100
6.20
-11.35% from price
SMA 200
5.78
-4.87% from price
EMA 12
5.85
-5.96% from price
EMA 26
6.29
-12.57% from price
EMA 50
6.49
-15.25% from price
RSI (14)
34.4
Neutral
MACD (12,26,9)
-0.44
Hist -0.03
ATR (14)
0.16
2.95% of price
Realised vol 30D
113.8%
Annualised
Bollinger upper
7.64
20, 2σ
Bollinger lower
4.59
20, 2σ
50 / 200 cross
Golden
6.97 vs 5.78
Trend bias
Below 200
-4.87%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.06
Less volatile than market
Correlation to SPY
0.01
Largely independent
Realised vol 30D
113.8%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-51.9%
Peak to trough
Max drawdown 5Y
-97.1%
Peak to trough
ATR 14
0.16
2.95% of price
Beta (reported)
2.13
5Y monthly, from filing
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 3, 26 | Citigroup | MAINTAINED | Neutral | Neutral |
| Jul 30, 26 | Canaccord Genuity | MAINTAINED | Buy | Buy |
| Jul 30, 26 | Evercore ISI Group | MAINTAINED | In-Line | In-Line |
| Jul 21, 26 | Canaccord Genuity | MAINTAINED | Buy | Buy |
| Jul 7, 26 | B of A Securities | MAINTAINED | Buy | Buy |
| May 5, 26 | Citigroup | MAINTAINED | Neutral | Neutral |
| Apr 8, 26 | Evercore ISI Group | MAINTAINED | In-Line | In-Line |
| Mar 26, 26 | Barclays | MAINTAINED | Equal-Weight | Equal-Weight |
| Mar 13, 26 | JP Morgan | MAINTAINED | Neutral | Neutral |
| Mar 10, 26 | Deutsche Bank | UPGRADE | Hold | Buy |
| Mar 3, 26 | Citigroup | MAINTAINED | Neutral | Neutral |
| Mar 3, 26 | Oppenheimer | MAINTAINED | Outperform | Outperform |
Headlines
FHLC vs. PJP: Which Healthcare ETF Is the Better Buy for Investors?
Motley Fool · 4m ago
Uber faces fine of nearly $1B over automated driver suspensions
TechCrunch · 14m ago
This Company Has Raised Its Dividend for 72 Straight Years. Almost Nobody Talks About It.
Motley Fool · 16m ago
This Chinese Tech Giant Quietly Cut Its Buyback 80% to Fund AI
24/7 Wall St. · 26m ago
Look Back: Long before Party on the Patio, Mötley Crüe rocked Pocono Downs
The Times-Leader (Wilkes-Barre, Pa.) · 27m ago
Prediction: ExxonMobil Raises Its Dividend More Than Wall Street Expects
Motley Fool · 28m ago
Amazon is selling Nothing noise-canceling earbuds for $59, and they 'stay in place comfortably for hours'
TheStreet · 29m ago
Linkdaze’s smart calendar is built to run a household, not just track a schedule
TechCrunch · 30m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.